ABSTRACT
Fluoroquinolones are broad-spectrum antibiotics increasingly utilized as empirical or prophylactic therapy in the management of cancer patients. We evaluated the effects of newer generation fluoroquinolones on the level of gastrointestinal (GI) colonization by Candida albicans in a previously established mouse model. Adult male Crl:CD1 (ICR) BR mice were fed chow containing Candida albicans or regular chow. The mice fed the Candida chow had their gut colonized by the yeast. Both groups were subsequently given levofloxacin, moxifloxacin, prulifloxacin or normal saline for 10 days. Stool cultures were performed immediately before, at the end, and one week after discontinuation of treatment to determine the level of intestinal yeast colonization. Candida-colonized mice treated with fluoroquinolones had substantially higher yeast counts in their stools than control mice fed Candida containing chow but treated with saline. Mice fed regular chow and treated with the study antibiotics or saline did not have any Candida in their stools. Dissemination of Candida to internal organs was not observed in any animal. In conclusion, we have shown that all fluoroquinolones tested induced substantial increases in the murine intestinal concentration of C. albicans.
Subject(s)
Anti-Bacterial Agents/administration & dosage , Aza Compounds/administration & dosage , Candida albicans/drug effects , Dioxolanes/administration & dosage , Fluoroquinolones/administration & dosage , Gastrointestinal Tract/microbiology , Levofloxacin , Ofloxacin/administration & dosage , Piperazines/administration & dosage , Quinolines/administration & dosage , Animals , Candida albicans/growth & development , Feces/microbiology , Male , Mice , Mice, Inbred ICR , Models, Animal , Moxifloxacin , Sodium ChlorideABSTRACT
Crl:CDI(ICR) BR adult mice were fed chow containing Candida albicans or regular chow. Both groups were subsequently given either antibiotics acting mainly against Gram-positive organisms or normal saline for 10 days. Stool cultures were performed before, at the end, and one week after discontinuation of treatment to determine the effects on the stool yeast concentration. Candida colonized mice treated with vancomycin, teicoplanin, linezolid, quinupristin-dalfopristin or telithromycin had higher colony counts of yeast in their stools than control Candida fed mice treated with saline. This increase was not statistically significant. Mice fed regular chow treated with the study drugs or saline did not have any yeasts in their stools. Dissemination of Candida was not observed in the visceral organs of any mouse.
Subject(s)
Anti-Bacterial Agents/adverse effects , Candida albicans/growth & development , Candidiasis/microbiology , Gastrointestinal Diseases/microbiology , Animals , Feces/microbiology , Mice , Mice, Inbred ICRABSTRACT
Bronchiolitis obliterans organizing pneumonia (BOOP) is an uncommon pulmonary disorder, the clinical spectrum of which is variable. We present a fatal case of BOOP, which developed spontaneous pneumothorax, a complication considered rare. Unusual was also the upper lobe distribution of the infiltrates. The histologically diagnosed disease failed to respond to antibiotics and corticosteroids and the 74-year-old patient eventually succumbed with acute respiratory distress syndrome, 50 days after disease onset. Spontaneous pneumothorax should be added to the complications of BOOP, which may adversely affect prognosis.
Subject(s)
Cryptogenic Organizing Pneumonia/complications , Pneumothorax/etiology , Aged , Cryptogenic Organizing Pneumonia/diagnostic imaging , Cryptogenic Organizing Pneumonia/microbiology , Fatal Outcome , Humans , Legionella pneumophila/isolation & purification , Pneumothorax/diagnostic imaging , Radiography, Thoracic , Tomography, X-Ray ComputedABSTRACT
Crl:CD1(ICR) BR mice were fed chow containing Candida albicans or regular chow. Both groups were subsequently given either antibiotics or normal saline. Stool cultures were performed before, at the end of treatment and 1 week after treatment, to determine the effect on the stool yeast concentration. Candida-colonized mice treated with cefepime, cefixime or ceftibuten had higher (however not significantly) counts of the yeast in their stools than control Candida-fed mice treated with saline. A group of Candida-fed mice were treated with ceftriaxone, which is known to increase the yeast stool concentration significantly and served as positive control. Mice fed regular chow and treated with the study drugs or saline did not have any yeasts in their stools. Dissemination of Candida did not occur.
Subject(s)
Antifungal Agents/pharmacology , Candida albicans/drug effects , Cefotaxime/analogs & derivatives , Cephalosporins/pharmacology , Digestive System/microbiology , Animals , Candidiasis/drug therapy , Candidiasis/microbiology , Cefepime , Cefixime , Cefotaxime/pharmacology , Ceftibuten , Digestive System/drug effects , Disease Models, Animal , Mice , Mice, Inbred ICRABSTRACT
Adult male Crl:CD1 (ICR) mice were fed chow containing Candida albicans to induce sustained gastrointestinal colonization by the yeast. Groups of mice were rendered neutropenic with cyclophosphamide and subsequently received ceftriaxone, while other groups received normal saline and served as controls. Stool cultures were obtained immediately before and at the end of treatment. The administration of cyclophosphamide substantially increased the C. albicans counts in the stools of mice. The addition of ceftriaxone to the cyclophosphamide regimen did not significantly increase the level of gastrointestinal colonization by C. albicans. There was no evidence of Candida dissemination to internal organs.
